New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
NYS Entity Status
NYS Filing Date
FEBRUARY 22, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - F & A CONCRETE INC.
2013 - F & A CONCREATE INC.
AROUND THE WEB
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
- Little girl doesn't really understand how fresh concrete works
By Jessica Sroczynski - Wednesday Aug 2, 2017
As far as botched concrete jobs go, this one is by far the cutest.
Tennessee based company, Porter Concrete Construction Co., posted photos on their Facebook on July 28 of a very adorable obstruction to their work.
Two-year-old, Izzidore Millaway, went looking for her parents in her family's basement. The company had just put down fresh concrete, so of course Izzidore left behind a trail of tiny footprints.
She looks so proud of her new artwork.
The construction workers poured back over the footprints but left one pair of feet as a little memento. Read more...More about Watercooler, Funny, Kids, Cute Kids, and Culture
- Inside New York City’s Priciest Rentals
By CAROLINE BIGGS - Friday Sep 1, 2017
Some New Yorkers could afford to buy multimillion-dollar properties, but they’d rather rent a place for upward of $20,000 a month.
- New York City and James Blake Resolve Excessive-Force Claim
By BENJAMIN MUELLER - Wednesday Jun 21, 2017
As part of the deal with the former pro tennis player, the city will create a new position within the agency that investigates police misconduct.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]